Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at <named-content content-type="genus-species">Streptococcus salivarius</named-content> as a Pathobiont-Inhibiting Species

ABSTRACT Chronic otitis media with effusion (OME) has been associated with a shift in microbiome composition and microbial interaction in the upper respiratory tract (URT). While most studies have focused on potential pathogens, this study aimed to find bacteria that could be protective against OME...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jennifer Jörissen, Marianne F. L. van den Broek, Ilke De Boeck, Wannes Van Beeck, Stijn Wittouck, An Boudewyns, Paul Van de Heyning, Vedat Topsakal, Vincent Van Rompaey, Ine Wouters, Liesbet Van Heirstraeten, Pierre Van Damme, Surbi Malhotra-Kumar, Heidi Theeten, Olivier M. Vanderveken, Sarah Lebeer
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/f3010fc6a30f4f54b4b7410413be9bd0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f3010fc6a30f4f54b4b7410413be9bd0
record_format dspace
spelling oai:doaj.org-article:f3010fc6a30f4f54b4b7410413be9bd02021-12-02T19:22:27ZCase-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at <named-content content-type="genus-species">Streptococcus salivarius</named-content> as a Pathobiont-Inhibiting Species10.1128/mSystems.00056-212379-5077https://doaj.org/article/f3010fc6a30f4f54b4b7410413be9bd02021-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00056-21https://doaj.org/toc/2379-5077ABSTRACT Chronic otitis media with effusion (OME) has been associated with a shift in microbiome composition and microbial interaction in the upper respiratory tract (URT). While most studies have focused on potential pathogens, this study aimed to find bacteria that could be protective against OME through a case-control microbiome study and characterization of isolates from healthy subjects. The URT and ear microbiome profiles of 70 chronic OME patients and 53 controls were compared by 16S rRNA amplicon sequencing. Haemophilus influenzae was the most frequent classic middle ear pathobiont. However, other taxa, especially Alloiococcus otitis, were also frequently detected in the ear canal of OME patients. Streptococci of the salivarius group and Acinetobacter lwoffii were more abundant in the nasopharynx of healthy controls than in OME patients. In addition to the microbiome analysis, 142 taxa were isolated from healthy individuals, and 79 isolates of 13 different Streptococcus species were tested for their pathobiont-inhibiting potential. Of these, Streptococcus salivarius isolates showed a superior capacity to inhibit the growth of H. influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, A. otitis, and Corynebacterium otitidis. S. salivarius strains thus show potential as a probiotic for prevention or treatment of OME based on their overrepresentation in the healthy nasopharynx and their ability to inhibit the growth of respiratory pathobionts. (This study has been registered at ClinicalTrials.gov under registration no. NCT03109496.) IMPORTANCE The majority of probiotics marketed today target gastrointestinal health. This study searched for bacteria native to the human upper respiratory tract, with a beneficial potential for respiratory and middle ear health. Comparison of the microbiomes of children with chronic otitis media with effusion (OME) and of healthy controls identified Streptococcus salivarius as a health-associated and prevalent inhabitant of the human nasopharynx. However, beneficial potential should be assessed at strain level. Here, we also isolated specific S. salivarius strains from the healthy individuals in our study. These isolates showed a beneficial safety profile and efficacy potential to inhibit OME pathogens in vitro. These properties will now have to be evaluated and confirmed in human clinical studies.Jennifer JörissenMarianne F. L. van den BroekIlke De BoeckWannes Van BeeckStijn WittouckAn BoudewynsPaul Van de HeyningVedat TopsakalVincent Van RompaeyIne WoutersLiesbet Van HeirstraetenPierre Van DammeSurbi Malhotra-KumarHeidi TheetenOlivier M. VandervekenSarah LebeerAmerican Society for Microbiologyarticle16S rRNAStreptococcus salivariusear canalmicrobiomemiddle earotitis mediaMicrobiologyQR1-502ENmSystems, Vol 6, Iss 2 (2021)
institution DOAJ
collection DOAJ
language EN
topic 16S rRNA
Streptococcus salivarius
ear canal
microbiome
middle ear
otitis media
Microbiology
QR1-502
spellingShingle 16S rRNA
Streptococcus salivarius
ear canal
microbiome
middle ear
otitis media
Microbiology
QR1-502
Jennifer Jörissen
Marianne F. L. van den Broek
Ilke De Boeck
Wannes Van Beeck
Stijn Wittouck
An Boudewyns
Paul Van de Heyning
Vedat Topsakal
Vincent Van Rompaey
Ine Wouters
Liesbet Van Heirstraeten
Pierre Van Damme
Surbi Malhotra-Kumar
Heidi Theeten
Olivier M. Vanderveken
Sarah Lebeer
Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at <named-content content-type="genus-species">Streptococcus salivarius</named-content> as a Pathobiont-Inhibiting Species
description ABSTRACT Chronic otitis media with effusion (OME) has been associated with a shift in microbiome composition and microbial interaction in the upper respiratory tract (URT). While most studies have focused on potential pathogens, this study aimed to find bacteria that could be protective against OME through a case-control microbiome study and characterization of isolates from healthy subjects. The URT and ear microbiome profiles of 70 chronic OME patients and 53 controls were compared by 16S rRNA amplicon sequencing. Haemophilus influenzae was the most frequent classic middle ear pathobiont. However, other taxa, especially Alloiococcus otitis, were also frequently detected in the ear canal of OME patients. Streptococci of the salivarius group and Acinetobacter lwoffii were more abundant in the nasopharynx of healthy controls than in OME patients. In addition to the microbiome analysis, 142 taxa were isolated from healthy individuals, and 79 isolates of 13 different Streptococcus species were tested for their pathobiont-inhibiting potential. Of these, Streptococcus salivarius isolates showed a superior capacity to inhibit the growth of H. influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, A. otitis, and Corynebacterium otitidis. S. salivarius strains thus show potential as a probiotic for prevention or treatment of OME based on their overrepresentation in the healthy nasopharynx and their ability to inhibit the growth of respiratory pathobionts. (This study has been registered at ClinicalTrials.gov under registration no. NCT03109496.) IMPORTANCE The majority of probiotics marketed today target gastrointestinal health. This study searched for bacteria native to the human upper respiratory tract, with a beneficial potential for respiratory and middle ear health. Comparison of the microbiomes of children with chronic otitis media with effusion (OME) and of healthy controls identified Streptococcus salivarius as a health-associated and prevalent inhabitant of the human nasopharynx. However, beneficial potential should be assessed at strain level. Here, we also isolated specific S. salivarius strains from the healthy individuals in our study. These isolates showed a beneficial safety profile and efficacy potential to inhibit OME pathogens in vitro. These properties will now have to be evaluated and confirmed in human clinical studies.
format article
author Jennifer Jörissen
Marianne F. L. van den Broek
Ilke De Boeck
Wannes Van Beeck
Stijn Wittouck
An Boudewyns
Paul Van de Heyning
Vedat Topsakal
Vincent Van Rompaey
Ine Wouters
Liesbet Van Heirstraeten
Pierre Van Damme
Surbi Malhotra-Kumar
Heidi Theeten
Olivier M. Vanderveken
Sarah Lebeer
author_facet Jennifer Jörissen
Marianne F. L. van den Broek
Ilke De Boeck
Wannes Van Beeck
Stijn Wittouck
An Boudewyns
Paul Van de Heyning
Vedat Topsakal
Vincent Van Rompaey
Ine Wouters
Liesbet Van Heirstraeten
Pierre Van Damme
Surbi Malhotra-Kumar
Heidi Theeten
Olivier M. Vanderveken
Sarah Lebeer
author_sort Jennifer Jörissen
title Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at <named-content content-type="genus-species">Streptococcus salivarius</named-content> as a Pathobiont-Inhibiting Species
title_short Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at <named-content content-type="genus-species">Streptococcus salivarius</named-content> as a Pathobiont-Inhibiting Species
title_full Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at <named-content content-type="genus-species">Streptococcus salivarius</named-content> as a Pathobiont-Inhibiting Species
title_fullStr Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at <named-content content-type="genus-species">Streptococcus salivarius</named-content> as a Pathobiont-Inhibiting Species
title_full_unstemmed Case-Control Microbiome Study of Chronic Otitis Media with Effusion in Children Points at <named-content content-type="genus-species">Streptococcus salivarius</named-content> as a Pathobiont-Inhibiting Species
title_sort case-control microbiome study of chronic otitis media with effusion in children points at <named-content content-type="genus-species">streptococcus salivarius</named-content> as a pathobiont-inhibiting species
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/f3010fc6a30f4f54b4b7410413be9bd0
work_keys_str_mv AT jenniferjorissen casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT marianneflvandenbroek casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT ilkedeboeck casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT wannesvanbeeck casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT stijnwittouck casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT anboudewyns casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT paulvandeheyning casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT vedattopsakal casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT vincentvanrompaey casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT inewouters casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT liesbetvanheirstraeten casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT pierrevandamme casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT surbimalhotrakumar casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT heiditheeten casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT oliviermvanderveken casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
AT sarahlebeer casecontrolmicrobiomestudyofchronicotitismediawitheffusioninchildrenpointsatnamedcontentcontenttypegenusspeciesstreptococcussalivariusnamedcontentasapathobiontinhibitingspecies
_version_ 1718376772453531648